Open AccessNo difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients
Author(s) -
Ajay J. Iyengar,
David S. Winlaw,
John C. Galati,
Gavin Wheaton,
Thomas L. Gentles,
Leeanne Grigg,
Robert Justo,
Dorothy J. Radford,
Chantal Attard,
Robert G. Weintraub,
Andrew Bullock,
Gary Sholler,
David S. Celermajer,
Yves d’Udekem
Publication year - 2016
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezw159
Subject(s) - warfarin , propensity score matching , aspirin , medicine , cardiology , fontan procedure , significant difference , atrial fibrillation , heart disease
The most effective method of long-term thromboprophylaxis after the Fontan procedure is not clear. We compared the rates of thromboembolic events between patients receiving aspirin and warfarin after an extracardiac conduit Fontan procedure in a bi-national registry.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom